Exclusive

Publication

Byline

Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi

Singapore, April 22 -- As part of its commitment to advance healthcare innovation, the Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has announced a du... Read More


Abu Dhabi establishes collaborative framework to shape future of healthcare with precision medicine

Singapore, April 21 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership with PureHealth, Khalifa University of technology (KU), Illumin... Read More


A new partnership between University of Melbourne and Thermo Fisher Scientific

Singapore, April 21 -- Researchers will be able to access cutting-edge tools to tackle society's most pressing challenges across healthcare, manufacturing and sustainability, owing to a new partnershi... Read More


Taipei Medical University and MSD launch collaboration to enhance healthcare innovation

Singapore, April 21 -- Taipei Medical University (TMU) and Merck Sharp & Dohme (MSD) Taiwan have signed a Memorandum of Understanding to collaborate in six key directions aiming to advance healthcare ... Read More


Korea's DAAN Biotherapeutics and GC Cell join hands to advance CAR-T and CAR-NK cell therapies

Singapore, April 21 -- South Korea-based DAAN Biotherapeutics, a leading innovative drug development company specialising in T-Cellreceptor (TCR)-based therapies, has signed an exclusive licensing agr... Read More


Abu Dhabi launches life sciences cluster to advance healthcare innovation globally

Singapore, April 18 -- Abu Dhabi has launched the groundbreaking life sciences cluster, reinforcing its position as a global hub for biotechnology, medtech, and digital health. Developed by the Abu Dh... Read More


Singapore's Duke-NUS and T Cells Diagnostics team up to simplify T-cell analysis

Singapore, April 18 -- T Cell Diagnostics (TCD) has licensed an intellectual property (IP) and its related know-how from Duke-NUS Medical School to develop point-of-care assays that could simplify the... Read More


Wayfinder Biosciences and Daiichi Sankyo to develop novel RNA-targeting therapies for neurodegenerative diseases

Singapore, April 18 -- US-based Wayfinder Biosciences has entered into a collaboration with Japanese pharma firm Daiichi Sankyo to develop RNA-targeting small molecule therapies aimed at treating neur... Read More


Thermo Fisher opens collaboration centre in US to help accelerate cell therapy development

Singapore, April 18 -- Thermo Fisher Scientific Inc. has announced the grand opening of its Advanced Therapies Collaboration Centre (ATxCC) in Carlsbad, California, US. This advanced facility is desig... Read More


Ready to Rethink Biosimilar CLD? Here's Your Front Row Seat

What to Expect, April 18 -- https://www.biospectrumasia.com/webinar-biosimilarcytiva Speakers Include: Why Attend: Whether you're navigating regulatory bottlenecks or striving to enhance manufacturi... Read More